Search Results

1 - 10 of 80 items :

  • "nanoparticles" x
  • Pharmacy, other x
Clear All
Spectrofluorimetric method for atenolol determination based on gold nanoparticles

triangular nanoplates and nanoparticle aggregates of gold, Adv. Mat. 21 (2009) 2309–2313; 6. A. D. McFarland, C. L. Haynes, C. A. Mirkin, R. P. V. Duyne and H. A. Godwin, Color my nanoworld, J. Chem. Ed . 81 (2004) 544A – 544B; 7. O. Stern and M. Volmer, Decay of fluorescence, J. Röntgen Soc. 15 (1919) 133–133; 8. International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use

Open access
Development and evaluation of coenzyme Q10 loaded solid lipid nanoparticle hydrogel for enhanced dermal delivery

-loaded solid lipid nanoparticles versus nanostructured lipid carriers: evaluation of antioxidant potential for dermal applications, Int. J. Nanomed. 7 (2012) 1841-1850; DOI: 10.2147%2FIJN.S29710. 11. E. S. Farboud. S. A. Nasrollahi and Z. Tabbakhi, Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies, Int. J. Nanomed. 6 (2011) 611-617; DOI: 10.2147%2FIJN.S16815. 12. K. Teskac and J. Kristl, The evidence for solid lipid nanoparticles mediated cell uptake of resveratrol, Int. J. Pharm

Open access
Dendrimer functionalized folate-targeted gold nanoparticles for luciferase gene silencing in vitro: A proof of principle study

.05.021 6. J. Turkevich, P. C. Stevenson and J. Hillier, A study of the nucleation and growth processes in the synthesis of colloidal gold, Discuss. Faraday Soc. 11 (1951) 55–75; https://doi:10.1039/DF9511100055 7. G. G. Lazarus, N. Revaprasadu, J. López-Viota and M. Singh, The electrokinetic characterization of gold nanoparticles, functionalized with cationic functional groups, and its interaction with DNA, Colloids Surf. B. 121 (2014) 425–431; 8. E. C. Wiener, S. Konda, A. Shadron, M. Brechbiel and O

Open access
Formulation and characterization of solid lipid nanoparticles, nanostructured lipid carriers and nanoemulsion of lornoxicam for transdermal delivery

humans: Passive versus iontophoretic delivery, Res. Pharm. Sci. 1 (2011) 76-79; DOI: 10.1016/j. rinphs.2011.11.001. 4. G. Yener, M. Uner, U. Gonullu, S. Yıldırım, P. Kılıc, S. Sağlık Aslan and A. Barla, Design of meloxicam and lornoxicam transdermal patches: Preparation, physical characterization, ex vivo and in vivo studies, Chem. Pharm. Bull. 58 (2010) 1466-1473; DOI: 10.1248/cpb.58.1466. 5. M. Uner, Preparation, characterization and physico-chemical properties of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC

Open access
Porous nanoparticles of metoprolol tartrate produced by spray-drying: development, characterization and in vitro evaluation

References 1. H. Q. Mao, K. Roy, V. L. Troung, K. A. Janes, K. Y. Lin, Y. Wang, J. T. August and K. W. Leong, Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency, J. Control. Release 70 (2001) 399-421; DOI: 10.1016/S0168-3659(00)00361-8. 2. K. A. Janes, P. Calvo and M. J. Alonso, Polysaccharide colloidal particles as delivery systems for macromolecules, Adv. Drug Del. Rev. 47 (2001) 83-97; DOI: 10.1016/S0169-409X(00)00123-X. 3. M. J. Alonso and A

Open access
Design and development of paclitaxel-loaded bovine serum albumin nanoparticles for brain targeting

References E. Baloglu and D. G. Kingston, The taxane diterpenoids, J. Nat. Prod.   62 (1999) 1448-1472. S. B. Horwitz, Taxol (paclitaxel): mechanisms of action, Annals Oncol.   5 (Suppl. 6) (1994) S3-S6. A. K. Singla, A. Garg and D. Aggarwal, Paclitaxel and its formulations, Int. J. Pharm.   235 (2002) 179-192; DOI: 10.1016/S0378-5173(01)00986-3. J. C. Olivier, Drug transport to brain with targeted nanoparticles, NeuroTherapeutics   2 (2005) 108

Open access
Biomimetic insulin-imprinted polymer nanoparticles as a potential oral drug delivery system

References 1. F. Nakayama, T. Yasuda, S. Umeda, M. Asada, T. Imamura, V. Meineke and M. Akashi, Fibroblast growth factor-12 (FGF12) translocation into intestinal epithelial cells is dependent on a novel cellpenetrating peptide domain involvement of internalization in the in vivo role of exogenous FGF12, J. Biol. Chem. 286 (2011) 25823-25834; DOI: 10.1074/jbc.M110.198267. 2. L. M. Ensign, R. Cone and J. Hanes, Oral drug delivery with polymeric nanoparticles: the gastrointestinal mucus barriers, Adv. Drug Deliv. Rev. 64 (2012

Open access
Evaluation of stability and in vitro wound healing potential of melatonin loaded (lipid enriched) chitosan based microspheres

. 42 (2017) 2–17; 11. J. Pardeike, A. Hommoss and R. H. Müller, Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products, Int. J. Pharm. 366 (2009) 170–184; 12. G. Gainza, M. Pastor, J. J. Aguirre, S. Villullas, J. L. Pedraz, R. M. Hernandez and M. Igartua, A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing

Open access
Effect of surface hydrophobicity of therapeutic protein loaded in polyelectrolyte nanoparticles on transepithelial permeability

:// 4. K. Park, I. C. Kwan and K. Park, Oral protein delivery: current status and future prospect, React. Funct. Polym. 71 (2011) 280–287; 5. D. Vllasaliu, R. Exposito-Harris, A. Heras, L. Casettari, M. Garnett, L. Illum and S. Stolnik, Tight junction modulation by chitosan nanoparticles: Comparison with chitosan solution, Int. J. Pharm . 400 (2010) 183–193; 6. G. Camenisch, J. Alsenz, H. V. Waterbeemd and G. Folkers

Open access
Stability studies of chitosan-DNA-FAP-B nanoparticles for gene delivery to lung epithelial cells

References S. Mansouria, Y. Cuieb, F. Winnikb, Q. Shia, P. Lavignea, M. Benderdoura, E. Beaumonta and J. C. Fernandes, Characterization of folate-chitosan-DNA nanoparticles for gene therapy, Biomaterials   27 (2006) 2060-2065; DOI: 10.1016/j.biomaterials.2005.09.020. Z. Cui and R. J. Mumper, Chitosan-based nanoparticles for topical genetic immunization, J. Control. Release   75 (2001) 409-419; DOI: 10.1016/s0168-3659(01)00407-2. F. C. MacLaughlin, R. J. Mumper, J. Wang, J. M

Open access